Skip to main content
Carlo Bifulco, MD, Pathology, New Haven, CT

CarloBrunoBifulcoMD

Pathology • New Haven, CT

Hematopathology, Molecular Genetics, Anatomic Pathology

Physician

Join to view full profile

Dr. Bifulco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bifulco's full profile

Already have an account?

  • Office

    20 York St
    Yale-New Haven Children's Hospital-Ep 2608
    New Haven, CT 06510
    Phone+1 203-785-3624
    Fax+1 203-785-7037

Education & Training

  • Memorial Sloan Kettering Cancer Center Oncologic Pathology
    Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 1998 - 2000
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1996 - 1997
  • Griffin Hospital
    Griffin HospitalInternship, Internal Medicine, 1995 - 1996
  • University of Milan Faculty of Medicine
    University of Milan Faculty of MedicineClass of 1994

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2008 - 2025
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Molecular Genetic Pathology

Publications & Presentations

PubMed

Abstracts/Posters

  • Flotetuzumab (FLZ), an Investigational CD123 x CD3 Bispecific Dart¬ Protein-Induced Clustering of CD3+ T Cells and CD123+ AML Cells in Bone Marrow Biopsies Is Associat...
    Carlo B Bifulco, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer
    Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced CancerNovember 13th, 2024
  • Blood Tests That Can Detect Cancer Are About to Hit the Market. But Experts Are Still Waiting to See if They Can Upend Deadly Disease
    Blood Tests That Can Detect Cancer Are About to Hit the Market. But Experts Are Still Waiting to See if They Can Upend Deadly DiseaseOctober 20th, 2021
  • Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All
    Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for AllAugust 18th, 2021
  • Join now to see all

Dr. Carlo Bifulco, Dr. Carlo Bifulco, MD, Dr. C Bifulco, Dr. Carlo Bruno Bifulco